EUVIMEDEUVIMED entdecken
Open Access

Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis

Congde Xu, Nastasia Roth, Carolin Heidel, Ute Hubauer, Stefan Wallner, Ralph Burkhardt, Christine Meindl, Andreas Holzamer, Michael Hilker, Marcus Creutzenberg, Samuel Sossalla, Lars Maier und 2 weitere

Biomarkers in Medicine · 2024

DOI: 10.1080/17520363.2024.2429366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomarkers in Medicine, 2024. Verfasst von Congde Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Acetylglucosaminidase, Aortic Valve Stenosis, Hepatitis A Virus Cellular Receptor 1, Peptide Fragments. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Cardiorenal syndrome (CRS) is common in severe aortic stenosis (AS). Previous studies revealed N-Acetylglucosaminidase (NAG) and Kidney-injury-molecule-1 (KIM-1) as potential markers for CRS. The study aimed to investigate the prognostic capability of NAG, KIM-1, NT-proBNP in severe AS before TAVI. MATERIALS & METHODS: Plasma and urine samples were collected from 151 participants before TAVI. Long-term follow-up (median follow-up time 31 months) was conducted to assess all-cause mortality and a composite endpoint of mortality and congestive heart failure. RESULTS: NT-proBNP was significantly elevated in classical low-flow, low-gradient AS compared to other severe AS phenotypes (p < 0.01), unlike NAG and KIM-1 (each p = n.s.). During follow-up, 40 patients (26.5%) died, and 58 patients (38.4%) reached the composite endpoint. Elevated baseline levels of NAG and KIM-1 were associated with increased risk of all-cause mortality in Kaplan-Meier analysis, like NT-proBNP (each p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylglucosaminidaseAortic Valve StenosisHepatitis A Virus Cellular Receptor 1Peptide FragmentsBiomarkersTranscatheter Aortic Valve ReplacementNatriuretic Peptide, BrainHumansMaleFemaleAgedPrognosisAged, 80 and overCardio-Renal SyndromeSeverity of Illness Index

Stichwörter der Autor:innen

KIM-1NAGNT-proBNPTAVITubular biomarkerscardiorenal syndromelong-term prognosis

Substanzen

AcetylglucosaminidaseHepatitis A Virus Cellular Receptor 1HAVCR1 protein, humanPeptide FragmentsBiomarkerspro-brain natriuretic peptide (1-76)Natriuretic Peptide, Brain

Autor:innen und Institutionen

  • Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.
  • Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Regensburg, Regensburg, Germany.
  • Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.
  • Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.

Zitieren

APA

Xu, C., Roth, N., Heidel, C., Hubauer, U., Wallner, S., Burkhardt, R., Meindl, C., Holzamer, A., Hilker, M., Creutzenberg, M., Sossalla, S., Maier, L., Debl, K., & Jungbauer, C. (2024). Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis. Biomarkers in Medicine. https://doi.org/10.1080/17520363.2024.2429366

Vancouver

Xu C, Roth N, Heidel C, Hubauer U, Wallner S, Burkhardt R, et al. Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis. Biomarkers in Medicine. 2024. doi:10.1080/17520363.2024.2429366

BibTeX
@article{Xu2024,
  author = {Xu, Congde and Roth, Nastasia and Heidel, Carolin and Hubauer, Ute and Wallner, Stefan and Burkhardt, Ralph and Meindl, Christine and Holzamer, Andreas and Hilker, Michael and Creutzenberg, Marcus and Sossalla, Samuel and Maier, Lars and Debl, Kurt and Jungbauer, Carsten},
  title = {Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis},
  journal = {Biomarkers in Medicine},
  year = {2024},
  doi = {10.1080/17520363.2024.2429366}
}
Kostenlos starten →